|
|
Cat. No |
Model |
Description |
Unit |
Price (VATº°µµ) |
³³±â |
Àç°í |
DataSheet |
ÁÖ¹®/°ßÀû |
LCA-23-350992 |
NBP1-20873 |
ABCF3 Antibody//Bovine, Canine/Goat |
1/EA |
|
|
|
|
¹®ÀÇ |
|
|
|
|
|
|
Subject
|
ABCF3 Antibody |
Description
|
/ Bovine, Canine/Goat |
Clonality
|
Poly |
Company
|
Novus biologicals |
Application
|
PEP-ELISA |
Conjugation
|
|
Immunogen
|
|
Contents
|
Description:Summary: Species: | Bv, Ca, Rt, Mu, Hu | Applications: | PEP-ELISA | Clonality: | Polyclonal | | Gene: | ABCF3 | Purity: | Immunogen affinity purified | Host: | Goat | | Specificity: | ABCF3 | Publications: | Antibody has not yet been mentioned in a publication. | Details: Isotype: | IgG | Immunogen: | Synthetic peptide, C-KESRLESSGKNKSYD, representing the C terminusof the sequence according to NP_060828.2 | Epitope: | C terminus | Gene Symbol: ABCF3 Entrez: | 55324 (Human) | | 287982 (Rat) | Swiss Prot: | NP_060828.2 (Human) | Related Genes: | ABCF1, ABCC3, ABCF2, ABCE1, ABCD3, ABCA12, ABCC4, ABCD1, EXOSC10, ABCB6, ABCC1, ABCA7, EXOSC7, MARCKSL1, LRP1B, ABCD4, ABCG1, GRM7, GPR177, HMOX1, ABCB4, ABCA3, ABCB1, ABCB5, RPLP2, SLC10A3, ABCB7, ABCC2, PMP2, ABCG4, ATP5G3, ALG3, ABCG8, ABCG5, ESRRA, PTPRG, ABCB10, HDAC9, ABCA5, RPS6KA4 | Species: Reactivity: | Human, Mouse, Rat, Dog, Cow | Applications: Uses: | Peptide ELISA: antibody detection limit dilution 1:128,000. Western Blot: Preliminary experiments in Human Liver lysates and in lysates of cell lines DAUDI and K562 gave no specific signal but low background (at antibody concentration up to 1ug/ml). We w | Dilutions: | Peptide ELISA 1:128000 | Concentrations: | 0.5 mg/ml | Packaging: Buffer: | Tris-saline [pH7.3] with 0.5% BSA | Storage: | Aliquot and store at -20C or -80C. Avoid freeze-thaw cycles. | Preservative: | 0.02% Sodium Azide | Limitations: | This product is for research use only and is not approved for use in humans or in clinical diagnosis. Products are guaranteed for 6 months from date of receipt, except for peptides and proteins which are guaranteed for 3 months. | |
|
|
|
|